Article
Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
Cancer genetics - 1 Sept 2016
Alemar Bárbara, Herzog Josef, Brinckmann Oliveira Netto Cristina, Artigalás Osvaldo, Schwartz Ida Vanessa D, Matzenbacher Bittar Camila, Ashton-Prolla Patricia, Weitzel Jeffrey N
Abstract excerpt
Germline mutations in BRCA1 or BRCA2 (BRCA) are responsible for 5-15% of breast (BC) and ovarian cancers (OC), predisposing to the development of early onset and often multiple primary tumors. Since mutation carriers can benefit from risk-reducing interventions, the identification of individuals with hereditary breast and ovarian cancer (HBOC) syndrome has a significant clinical impact. We assessed whether a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
